| Company Name: |
T&W GROUP |
| Tel: |
021-61551611 13296011611 |
| Email: |
contact@trustwe.com |
N6-Benzoyl-3'-O-(2-methoxyethyl)adenosine manufacturers
|
| | N6-Benzoyl-3'-O-(2-methoxyethyl)adenosine Basic information |
| Product Name: | N6-Benzoyl-3'-O-(2-methoxyethyl)adenosine | | Synonyms: | N6-Benzoyl-3'-O-(2-methoxyethyl)adenosine;3'-MOE-N2-Bz-Adenosine;Adenosine, N-benzoyl-3'-O-(2-methoxyethyl)- (9CI);N6-Benzoyl-3’-O-(2-methoxyethyl)adenosine;N-(9-((2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-(2-methoxyethoxy)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide | | CAS: | 256223-99-1 | | MF: | C20H23N5O6 | | MW: | 429.43 | | EINECS: | | | Product Categories: | | | Mol File: | 256223-99-1.mol |  |
| | N6-Benzoyl-3'-O-(2-methoxyethyl)adenosine Chemical Properties |
| density | 1.53±0.1 g/cm3(Predicted) | | pka | 7.87±0.43(Predicted) |
| | N6-Benzoyl-3'-O-(2-methoxyethyl)adenosine Usage And Synthesis |
| Uses | N6-Benzoyl-3’-O-(2-methoxyethyl)adenosine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | N6-Benzoyl-3'-O-(2-methoxyethyl)adenosine Preparation Products And Raw materials |
|